Your browser doesn't support javascript.
loading
Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma.
Fontanilles, M; Deniel, A; Marguet, F; Beaussire, L; Magne, N; Derrey, S; Blanchard, F; Alexandru, C; Coutant, S; Laquerrière, A; Clatot, F; Di Fiore, F; Sarafan-Vasseur, N.
Affiliation
  • Fontanilles M; UNIROUEN, Inserm U1245, IRON group, Normandy Centre for Genomic and Personalized Medicine, Normandie university, Rouen University Hospital, 76031 Rouen, France; Department of Medical Oncology, Cancer Centre Henri Becquerel, 76000 Rouen, France. Electronic address: maxime.fontanilles@chb.unicancer.fr
  • Deniel A; Department of Medical Oncology, Cancer Centre Henri Becquerel, 76000 Rouen, France.
  • Marguet F; Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen, France; Department of Pathology, Rouen University Hospital, 76031 Rouen, France.
  • Beaussire L; UNIROUEN, Inserm U1245, IRON group, Normandy Centre for Genomic and Personalized Medicine, Normandie university, Rouen University Hospital, 76031 Rouen, France.
  • Magne N; Department of Radiology, Rouen University Hospital, 76031 Rouen, France.
  • Derrey S; Department of Neurosurgery, Rouen University Hospital, 76031 Rouen, France.
  • Blanchard F; Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen, France; Department of Pathology, Rouen University Hospital, 76031 Rouen, France.
  • Alexandru C; Department of Medical Oncology, Cancer Centre Henri Becquerel, 76000 Rouen, France.
  • Coutant S; UNIROUEN, Inserm U1245, IRON group, Normandy Centre for Genomic and Personalized Medicine, Normandie university, Rouen University Hospital, 76031 Rouen, France.
  • Laquerrière A; Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen, France; Department of Pathology, Rouen University Hospital, 76031 Rouen, France.
  • Clatot F; UNIROUEN, Inserm U1245, IRON group, Normandy Centre for Genomic and Personalized Medicine, Normandie university, Rouen University Hospital, 76031 Rouen, France; Department of Medical Oncology, Cancer Centre Henri Becquerel, 76000 Rouen, France.
  • Di Fiore F; UNIROUEN, Inserm U1245, IRON group, Normandy Centre for Genomic and Personalized Medicine, Normandie university, Rouen University Hospital, 76031 Rouen, France; Department of Medical Oncology, Cancer Centre Henri Becquerel, 76000 Rouen, France; Department of Hepatogastroenterology, Rouen University
  • Sarafan-Vasseur N; UNIROUEN, Inserm U1245, IRON group, Normandy Centre for Genomic and Personalized Medicine, Normandie university, Rouen University Hospital, 76031 Rouen, France.
Rev Neurol (Paris) ; 178(9): 975-980, 2022 Nov.
Article de En | MEDLINE | ID: mdl-35871016
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glioblastome / ADN tumoral circulant / Gliome Type d'étude: Diagnostic_studies / Observational_studies Limites: Humans Langue: En Journal: Rev Neurol (Paris) Année: 2022 Type de document: Article Pays de publication: France
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glioblastome / ADN tumoral circulant / Gliome Type d'étude: Diagnostic_studies / Observational_studies Limites: Humans Langue: En Journal: Rev Neurol (Paris) Année: 2022 Type de document: Article Pays de publication: France